BRIEF published on 05/13/2026 at 07:05, 2 hours 15 minutes ago SCHOTT Pharma annonce un premier semestre résilient et un flux de trésorerie solide SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Des Flux De Trésorerie Résultats De La Première Mi-temps
BRIEF published on 05/13/2026 at 07:05, 2 hours 15 minutes ago SCHOTT Pharma Reports Resilient First Half and Strong Cash Flow Revenue Growth Cash Flow EBITDA Margin SCHOTT Pharma First Half Results
PRESS RELEASE published on 05/13/2026 at 07:00, 2 hours 20 minutes ago SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow SCHOTT Pharma reports robust first half with strong cash flow, exceeding revenue forecast and confirming full-year outlook for 2026 Financial Results Revenue Cash Flow SCHOTT Pharma H1 2026
BRIEF published on 02/11/2026 at 07:05, 3 months 2 days ago SCHOTT Pharma annonce un bon début d'année 2026 SCHOTT Pharma Augmentation Des Revenus Croissance De L'EBITDA Exercice Financier 2026 Solutions De Confinement Des Médicaments
BRIEF published on 02/11/2026 at 07:05, 3 months 2 days ago SCHOTT Pharma Reports a Strong Beginning to 2026 Revenue Increase SCHOTT Pharma EBITDA Growth Financial Year 2026 Drug Containment Solutions
PRESS RELEASE published on 02/11/2026 at 07:00, 3 months 2 days ago SCHOTT Pharma with positive start to financial year 2026; outlook confirmed SCHOTT Pharma reports positive Q1 results for 2026 with revenue growth and increased EBITDA margin. Outlook confirmed for the year Revenue Growth EBITDA Margin SCHOTT Pharma Q1 Results 2026 Outlook
BRIEF published on 02/03/2026 at 15:05, 3 months 9 days ago All Resolutions Passed at SCHOTT Pharma's AGM Shareholders Dividend Pharmaceutical AGM Resolutions
BRIEF published on 02/03/2026 at 15:05, 3 months 9 days ago Toutes les résolutions ont été adoptées lors de l'assemblée générale annuelle de SCHOTT Pharma. Actionnaires Dividende Resolutions Assemblée Générale Annuelle Pharmaceutique
PRESS RELEASE published on 02/03/2026 at 15:00, 3 months 9 days ago Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved SCHOTT Pharma AG & Co. KGaA had a successful Annual General Meeting with all resolutions approved, including a dividend of 0.18 EUR per share for fiscal year 2025 Annual General Meeting Shareholders Dividend SCHOTT Pharma Resolutions
BRIEF published on 12/11/2025 at 07:05, 5 months 2 days ago SCHOTT Pharma Achieves Full-Year Revenue and Profitability Targets Revenue Growth EBITDA Margin SCHOTT Pharma Drug Delivery Systems Drug Containment Solutions
Published on 05/13/2026 at 08:05, 1 hour 15 minutes ago Tocvan Announces New Surface Gold-Silver Results, Outlining New Target 3 Kilometers East of Main Zone at Gran Pilar Gold-Silver Project
Published on 05/13/2026 at 00:00, 9 hours 20 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 9 hours 45 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 11 hours 25 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/13/2026 at 09:08, 12 minutes ago AUSTRIACARD HOLDINGS AG and Dai Nippon Printing agree strategic framework for intended voluntary public takeover offer, irrevocable undertaking from major shareholder available
Published on 05/13/2026 at 09:05, 15 minutes ago OneLayer Launches Technology Alliance Program to Advance Secure Private Cellular Adoption
Published on 05/13/2026 at 09:00, 19 minutes ago Original-Research: INDUS Holding AG (von NuWays AG): BUY
Published on 05/13/2026 at 09:00, 19 minutes ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 05/13/2026 at 06:55, 2 hours 25 minutes ago Recticel Group realiseert doorbraak in PIR circulariteit met gerecycleerde polyol
Published on 05/13/2026 at 06:55, 2 hours 25 minutes ago Recticel Group closes the loop on PIR circularity with industrial scale recycled polyol plant
Published on 05/12/2026 at 18:15, 15 hours 5 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 15 hours 5 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 15 hours 10 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
